Catalyst Pharmaceuticals Inc (CPRX)
21.48
+0.36
(+1.70%)
USD |
NASDAQ |
Nov 22, 16:00
21.47
-0.01
(-0.05%)
After-Hours: 20:00
Catalyst Pharmaceuticals Revenue (Annual): 398.20M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 398.20M |
| December 31, 2022 | 214.20M |
| December 31, 2021 | 140.83M |
| December 31, 2020 | 119.07M |
| December 31, 2019 | 102.31M |
| December 31, 2018 | 0.50M |
| December 31, 2017 |
| Date | Value |
|---|---|
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | 0.489M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
102.31M
Minimum
2019
398.20M
Maximum
2023
194.92M
Average
140.83M
Median
2021
Revenue (Annual) Benchmarks
| Corcept Therapeutics Inc | 482.38M |
| Vertex Pharmaceuticals Inc | 9.869B |
| Sarepta Therapeutics Inc | 1.243B |
| ADMA Biologics Inc | 258.22M |
| BioVie Inc | -- |